Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Mol Genet Metab ; 111(2): 205-8, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24359664

RESUMEN

Mucopolysaccharidosis IVA is a lysosomal storage disorder leading to an increase in glycosaminoglycans storage. Genistein is an isoflavone capable to inhibit glycosaminoglycans production. The objective of this study was to analyze the in vitro effect of different concentrations of genistein on DNA injury in mucopolysaccharidosis IVA patients. The lower concentration tested (10 µM) showed a significant increase on DNA injury in vitro, although higher concentrations (30 µM and 50 µM) showed higher DNA damage.


Asunto(s)
Genisteína/farmacología , Leucocitos Mononucleares/efectos de los fármacos , Mucopolisacaridosis IV/patología , Adolescente , Adulto , Células Cultivadas , Niño , Ensayo Cometa , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Leucocitos Mononucleares/patología , Masculino
2.
Cell Mol Neurobiol ; 31(3): 429-36, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21191647

RESUMEN

It is well established that the involvement of reactive species in the pathophysiology of several neurological diseases, including phenylketonuria (PKU), a metabolic genetic disorder biochemically characterized by elevated levels of phenylalanine (Phe). In previous studies, we verified that PKU patients (treated with a protein-restricted diet supplemented with a special formula not containing L-carnitine and selenium) presented high lipid and protein oxidative damage as well as a reduction of antioxidants when compared to the healthy individuals. Our goal in the present study was to evaluate the effect of Phe-restricted diet supplemented with L-carnitine and selenium, two well-known antioxidant compounds, on oxidative damage in PKU patients. We investigated various oxidative stress parameters in blood of 18 treated PKU patients before and after 6 months of supplementation with a special formula containing L-carnitine and selenium. It was verified that treatment with L-carnitine and selenium was capable of reverting the lipid peroxidation, measured by thiobarbituric acid-reactive species, and the protein oxidative damage, measured by sulfhydryl oxidation, to the levels of controls. Additionally, the reduced activity of glutathione peroxidase was normalized by the antioxidant supplementation. It was also verified a significant inverse correlation between lipid peroxidation and L-carnitine blood levels as well as a significant positive correlation between glutathione peroxidase activity and blood selenium concentration. In conclusion, our results suggest that supplementation of L-carnitine and selenium is important for PKU patients since it could help to correct the oxidative stress process which possibly contributes, at least in part, to the neurological symptoms found in phenylketonuric patients.


Asunto(s)
Antioxidantes/farmacología , Carnitina/farmacología , Estrés Oxidativo/efectos de los fármacos , Fenilcetonurias/fisiopatología , Selenio/farmacología , Adolescente , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Carnitina/administración & dosificación , Carnitina/uso terapéutico , Suplementos Dietéticos , Humanos , Fenilcetonurias/sangre , Fenilcetonurias/dietoterapia , Especies Reactivas de Oxígeno/metabolismo , Selenio/administración & dosificación , Selenio/uso terapéutico , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Adulto Joven
4.
Biochim Biophys Acta ; 718(1): 21-5, 1982 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-7138903

RESUMEN

The release of hydrogen peroxide from human blood platelets after stimulation with particulate membrane-perturbing agents has been determined by fluorescence using scopoletin as the detecting agent. Platelet suspensions containing less than 1 polymorphonuclear leukocyte/10(8) platelets showed a significant release of hydrogen peroxide (6.11 nmol/10(9) platelets per 20 min, S.D., 0.26, n = 9) after addition of zymosan or latex particles, compared to unstimulated platelets. The release of hydrogen peroxide was only observed when the scopoletin was added to the platelet suspensions during the stimulation. Any attempt to determine hydrogen peroxide release in the supernatant at the end of the incubation with zymosan or latex failed. A NADH-dependent production of hydrogen peroxide was observed by measuring the difference of oxygen uptake in the presence and absence of catalase (500 units), which was not inhibited by potassium cyanide (1 mM). By this method the NADH-dependent cyanide-insensitive peroxide production and release was 6.0 nmol/10(9) platelets per 20 min from resting platelets (S.D., 2, n = 6) vs 15 nmol/10(9) platelets per 20 min from stimulated platelets (S.D., 2, n = 6).


Asunto(s)
Plaquetas/metabolismo , Peróxido de Hidrógeno/sangre , Catalasa/farmacología , Humanos , Cinética , NAD/farmacología , Neutrófilos/fisiología , Oxidación-Reducción , Consumo de Oxígeno/efectos de los fármacos , Cianuro de Potasio/farmacología , Escopoletina/sangre
5.
Thromb Haemost ; 46(3): 581-3, 1981 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7031980

RESUMEN

Thrombin incubated with 2,3-diphosphoglycerate (150 nmol 2,3-DPG/1 NIH thrombin unit) lost up to 70% of its clotting activity, whereas the esterase activity remained unchanged. No fibrinopeptide release by thrombin was observed in the presence of 2,3-DPG. The fibrin polymerization was normal. By chromatography on Amberlite IRC-50, alpha-thrombin was eluted at pH 8.0. In presence of 2,3-DPG, alpha-thrombin was not eluted. Likely, 2,3-DPG can interfere with thrombin.


Asunto(s)
Ácidos Difosfoglicéricos/farmacología , Trombina/antagonistas & inhibidores , Animales , Anticoagulantes , Coagulación Sanguínea/efectos de los fármacos , Bovinos , Cromatografía por Intercambio Iónico/métodos , Depresión Química , Fibrina/fisiología , Fibrinógeno/fisiología , Fibrinopéptido A/antagonistas & inhibidores , Fibrinopéptido B/antagonistas & inhibidores , Humanos , Técnicas In Vitro , Péptido Hidrolasas/sangre
6.
J Chromatogr ; 342(2): 285-92, 1985 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-3863832

RESUMEN

Cerebrospinal fluid proteins from 42 children with acute lymphoblastic leukaemia were analysed by isotachophoresis. The isotachopherograms of cerebrospinal fluid taken from patients undergoing central nervous system prophylaxis with neurological complications showed an increase of several peaks (albumin, prealbumin, and an unidentified peak), and changes in the globulin zone, compared with those from patients who had completed central nervous system prophylaxis for at least six months. The most striking finding was that these alterations were not associated with any other biochemical changes in the cerebrospinal fluid, as assayed by routine analysis. Isotachophoresis may be useful in the monitoring of therapy in children affected with acute lymphoblastic leukaemia.


Asunto(s)
Encefalopatías/líquido cefalorraquídeo , Proteínas del Líquido Cefalorraquídeo/análisis , Leucemia Linfoide/líquido cefalorraquídeo , Neoplasias Meníngeas/líquido cefalorraquídeo , Encefalopatías/etiología , Niño , Electroforesis , Humanos , Leucemia Linfoide/complicaciones , Espectrofotometría Ultravioleta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA